focus -WSS

focus

author：entertainment 2025-09-30 14:58:02 - browse：6135

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

WSS

NIH chief: government has fallen behind pharma on clinical trials

NIH chief: government has fallen behind pharma on clinical trials

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Gene therapy has helped boys walk. Can scientists keep it that way?

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

hotspot

focus

knowledge

Sports medicine is finally prioritizing gender equality

White House drug czar issues call for 'recovery

Duchenne breakthrough therapy leaves behind pioneering families

Donald Trump's relentless attacks on special counsel Jack Smith

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Wildfire smoke exposes gaps in outdoor worker protections

Colonoscopy at 40? Study finds a possible benefit

Medical leaders decry Supreme Court decision on affirmative action

The story of mRNA: From a loose idea to a tool that may help curb Covid

focus

The story of mRNA: From a loose idea to a tool that may help curb Covid

The strategy behind pharma's lawsuits over drug pricing reform

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Why drug prescriptions should include diagnoses

CDC concerned about possible undetected monkeypox spread in U.K.

Ventyx halts psoriasis drug development after lackluster trial results

focus

focus

leisure time

focus